SonoScape Medical Corp. (SZSE:300633) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
SonoScape Medical Corp. (SZSE:300633) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
It is hard to get excited after looking at SonoScape Medical's (SZSE:300633) recent performance, when its stock has declined 9.0% over the past week. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in value in the long-term, given how markets usually reward companies with good financial health. Specifically, we decided to study SonoScape Medical's ROE in this article.
观察到SonoScape Medical(SZSE:300633)近期表现下滑9.0%之后,很难感到兴奋。但是,如果您密切关注,您可能会发现其强大的财务状况意味着该股票在长期内可能会看到价值上涨,因为市场通常会奖励拥有良好财务状况的公司。本文决定研究SonoScape Medical的roe。
Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.
股东权益回报率(ROE)是检验公司增加其价值和管理投资者资金有效性的测试。简而言之,ROE显示每个美元的利润与其股东的投资有关。
How To Calculate Return On Equity?
如何计算股东权益报酬率?
The formula for ROE is:
roe的公式是:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
净资产收益率 = 净利润(从持续经营中获得)÷ 股东权益
So, based on the above formula, the ROE for SonoScape Medical is:
因此,根据上述公式,SonoScape Medical的roe为:
13% = CN¥416m ÷ CN¥3.3b (Based on the trailing twelve months to March 2024).
13%= CN¥41600万 ÷ CN¥33亿(基于截至2024年3月的过去十二个月)。
The 'return' refers to a company's earnings over the last year. Another way to think of that is that for every CN¥1 worth of equity, the company was able to earn CN¥0.13 in profit.
'回报'是指公司过去一年的收益。换句话说,对于每一元人民币的净值,公司能够获得0.13元的利润。
Why Is ROE Important For Earnings Growth?
ROE为什么对净利润增长很重要?
We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.
我们已经确定,roe可以作为一种有效的衡量公司未来盈利能力的指标。现在我们需要评估公司再投资或“保留”的利润有多少,这就给我们提供了有关公司增长潜力的想法。假设其他一切不变,roe和利润保留率越高,公司的增长率就越高,而不一定具备这些特征的公司相比。
SonoScape Medical's Earnings Growth And 13% ROE
SonoScape Medical的净利润增长率和13%的roe
At first glance, SonoScape Medical seems to have a decent ROE. Further, the company's ROE compares quite favorably to the industry average of 7.4%. This certainly adds some context to SonoScape Medical's exceptional 35% net income growth seen over the past five years. We reckon that there could also be other factors at play here. Such as - high earnings retention or an efficient management in place.
乍一看,SonoScape Medical的roe似乎不错。此外,该公司的roe相比于业内平均7.4%比较有优势。这为SonoScape Medical过去5年出色的35%的净利润增长增添了一些背景。我们认为这里可能还有其他因素在起作用,例如-高盈利保留或者是有效率的管理。
We then compared SonoScape Medical's net income growth with the industry and we're pleased to see that the company's growth figure is higher when compared with the industry which has a growth rate of 7.0% in the same 5-year period.
然后,我们将SonoScape Medical的净利润增长与行业相比较,我们很高兴地看到在同样的5年时间段内,公司的增长率比行业高,行业增长率为7.0%。
![past-earnings-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240702/0-7af76accef19b819f58ee2e7a699cdd5-0-0ccd5f053f97e9382350aaf74f66476b.png/big)
Earnings growth is a huge factor in stock valuation. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if SonoScape Medical is trading on a high P/E or a low P/E, relative to its industry.
收益增长是股票估值的一个重要因素。投资者应该试图确定预期收益增长或下降是是否计入价格的。通过这样做,他们将了解股票是朝着清晰的蓝水领域还是可能会遭遇沼泽水域。预期收益增长的一个好指标是P/E比率,它确定市场愿意根据其收益前景为股票支付的价格。因此,您可能需要检查SonoScape Medical的P/E比率是否高于行业或低于行业。
Is SonoScape Medical Making Efficient Use Of Its Profits?
SonoScape Medical是否有效利用其利润?
SonoScape Medical's three-year median payout ratio to shareholders is 18%, which is quite low. This implies that the company is retaining 82% of its profits. So it seems like the management is reinvesting profits heavily to grow its business and this reflects in its earnings growth number.
SonoScape Medical向股东派发三年的中位数股息支付比率为18%,这相当低。这意味着公司保留了82%的利润。所以看起来管理层在大量重新投资利润以推动业务增长,这反映在其盈利增长数字上。
Besides, SonoScape Medical has been paying dividends over a period of seven years. This shows that the company is committed to sharing profits with its shareholders. Upon studying the latest analysts' consensus data, we found that the company's future payout ratio is expected to rise to 27% over the next three years. Still, forecasts suggest that SonoScape Medical's future ROE will rise to 17% even though the the company's payout ratio is expected to rise. We presume that there could some other characteristics of the business that could be driving the anticipated growth in the company's ROE.
此外,SonoScape Medical在过去七年中一直在支付分红派息。这表明公司致力于与股东分享利润。通过研究最新的分析师共识数据,我们发现公司未来的分红派息比率有望在未来三年内上升到27%。尽管这样,预测表明SonoScape Medical的未来roe将提高到17%,即使公司的分红派息比率有望上升,我们认为可能还有一些该公司业务的其他特点可能驱动了其预期的roe增长。
Summary
总的来说,我们对伟明环保的表现非常满意。具体而言,我们喜欢公司以高回报率再投资了其利润的很大一部分。当然,这导致公司的收益大幅增长。但是,最新的行业分析师预测表明,该公司的收益预计将加速增长。
Overall, we are quite pleased with SonoScape Medical's performance. Particularly, we like that the company is reinvesting heavily into its business, and at a high rate of return. Unsurprisingly, this has led to an impressive earnings growth. That being so, a study of the latest analyst forecasts show that the company is expected to see a slowdown in its future earnings growth. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.
总的来说,我们对SonoScape Medical的业绩感到相当满意。特别是,我们喜欢该公司大量重新投资并以高回报率推动业务增长。不出所料,这已经导致了令人印象深刻的盈利增长。即使如此,对最新分析师预测的研究显示,该公司未来的盈利增长预计将放缓。要了解有关该公司最新分析师预测的更多信息,请查看该公司的分析师预测可视化。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈?关于内容有所顾虑?直接和我们联系。或电邮 editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,也可以发送电子邮件至editorial-team@simplywallst.com